The U.S. Food and Drug Administration (FDA) has cautioned against the consumption and sale of specific oysters harvested in Canada and distributed in the United States. The warning comes in response to two confirmed cases of Campylobacter jejuni infection associated with the consumption of oysters from British Columbia, Canada.
On December 18, the Utah Shellfish Authority reported two instances of Campylobacter infection linked to oyster consumption from British Columbia. The FDA promptly notified the Canadian Food Inspection Agency (CFIA), initiating an investigation into the source of contamination. The affected individuals consumed the oysters in Utah and Wisconsin, prompting collaboration between the FDA, CFIA, and state authorities to assess potential further distribution.
Affected Oysters: The FDA advises against the consumption and sale of oysters from Pacific Oyster Fanny Bay, harvested on November 8 from the harvest area BC 14-8 with Landfile #1402294, and Oyster Malaspina Live, harvested on November 9 from the same harvest area with Landfile #278761. These oysters were shipped to distributors in Utah and Wisconsin.
The FDA recommends that restaurants and food retailers refrain from serving or selling these specific oysters and dispose of any remaining stock. Consumers are urged not to eat oysters from the mentioned batches.
Campylobacter Risks: Oysters contaminated with Campylobacter jejuni pose a risk of illness, particularly when consumed raw. While the symptoms can be severe, contaminated food may appear normal in terms of appearance, smell, and taste. Individuals experiencing symptoms such as diarrhea (often bloody), fever, stomach cramps, nausea, and vomiting should seek medical attention and report their condition to local health authorities.
Complications and Risks: Campylobacter infections may lead to complications, including irritable bowel syndrome, temporary paralysis, and arthritis. In individuals with weakened immune systems, such as those with blood disorders, AIDS, or undergoing chemotherapy, Campylobacter can potentially spread to the bloodstream, causing life-threatening infections.
As the investigation unfolds, the FDA awaits further information from the CFIA regarding the distribution of the affected oysters. The agency remains committed to monitoring the situation and providing assistance to state authorities as needed. Consumers are strongly encouraged to exercise caution and adhere to the FDA’s guidance to prevent potential health risks associated with these specific oysters.